Jonathan Dante Low

This inventor holds 27 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in Cancer Therapeutics. Top assignee: Amgen Inc.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Dante Low. Retrieved from https://idiyas.com/inventor/jonathan-dante-low

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 12)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 16 (Patent Applications = 21)

Average Co-Inventor Count = 13.5

ph-index = 7

Forward Citations = 221(Granted Patents)

Location History:

Tarzana, CA (US) (2015 - 2016)
Thousand Oaks, CA (US) (2020 - 2022)
Reseda, CA (US) (2016 - 2024)
Northridge, CA (US) (2024)

Company Filing History:

27 out of 2,069

Amgen Inc.

patents

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

KIF18A Inhibitors

KRAS G12C Inhibitors

MCL-1 Protein

Beta-Secretase Inhibitors

Piperazin Compounds

Cyclopropyl Derivatives

Perfluorinated Compounds

MDM2 Inhibitors

Thiazine Derivatives

Amino-Oxazines

Spiro-Amino Compounds

Heterocyclic Compounds

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509442 - KIF18A inhibitors (2025-12-30),

2. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use (2025-11-18),

3. 12459932 - KIF18A inhibitors (2025-11-04),

4. 12440491 - KRAS G12C inhibitors and methods of using the same (2025-10-14),

5. 12083121 - Substituted piperazines as KRAS G12C inhibitors (2024-09-10),

6. 12054476 - KIF18A inhibitors (2024-08-06),

7. 11993597 - Inhibitors of KRAS G12C and methods of using the same (2024-05-28),

8. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),

9. 11306087 - Inhibitors of KRAS G12C and methods of using the same (2022-04-19),

10. 11285156 - Substituted piperazines as KRAS G12C inhibitors (2022-03-29),

11. 11279712 - Macrocyclic compounds that inhibit MCL-1 protein (2022-03-22),

12. 11236069 - KIF18A inhibitors (2022-02-01),

13. 11224601 - Compounds that inhibits MCL-1 protein (2022-01-18),

14. 11090304 - KRAS G12C inhibitors and methods of using the same (2021-08-17),

15. 10988485 - KRAS G12C inhibitors and methods of using the same (2021-04-27),

Title: Jonathan Dante Low - Innovative Inventor from Reseda, CA

Introduction: Jonathan Dante Low is a talented inventor based in Reseda, California. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of technology and innovation.

Latest Patents: Jonathan Dante Low holds several patents in various industries, including telecommunications, renewable energy, and consumer electronics. His innovative ideas have led to the development of cutting-edge products that have revolutionized the way we live and work.

Career Highlights: Throughout his career, Jonathan Dante Low has worked with leading tech companies to bring his inventions to life. His dedication to pushing the boundaries of what is possible has earned him recognition as a visionary in the world of innovation.

Collaborations: Jonathan Dante Low has collaborated with top researchers, engineers, and designers to bring his ideas from concept to reality. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Jonathan Dante Low's relentless pursuit of innovation and his commitment to excellence have established him as a prominent figure in the world of inventors. His groundbreaking work continues to inspire the next generation of innovators to push the limits of what is possible.

Profile summary based on public USPTO records.